Acta Pharmaceutica · 2008 · 47 citations · 10 references
PharmacyMedicinal ChemistryPharmacologyPharmacodynamicsStructure-activity RelationshipsSynthetic Medicinal ChemistryCardiac MedicationsIn Vitro PharmacologyPotency OptimizationStructure-activity Relationship AnalysisFriedel-crafts AcylationMedicinal Chemistry ApplicationsMedicinal HeterocyclesPharmacological PotencyPharmacological ScreeningPyridazine ChemistryPyridine Chemistry
The present study describes the synthesis and pharmacological evaluation of 2-substituted-6-(4-acylaminophenyl)-4,5-dihydropyridazin-3(2H)-ones as potent inodilating agents. The synthesis of target compounds 2-4 and 7-11 was achieved by Friedel-Crafts acylation of appropriate anilide derivative with succinic anhydride or methylsuccinic anhydride and subsequent cyclization of intermediary keto acids with various hydrazine derivatives. The newly synthesized pyridazinone derivatives were evaluated for cardiotonic activity using isolated rat atria and for vasorelaxant activity using descending thoracic aortic rings of Wistar rats precontracted with phenylephrine (10-6 mol L-1). 6-(4-Methanesulfonamidophenyl)-2-phenyl-4,5-dihydropyridazin-3(2H)-one (7) exhibited significant inodilatory properties and showed vasorelaxant activity in a nanomolar range (IC50 = 0.08 +/- 0.01 mumol L-1).
10
Energy crops: current status and future prospects
Ralph Sims, Astley Hastings, Bernhard Schlamadinger et al. · Global Change Biology · 2006 · 492 citations
Agriculture, Agronomy, Crop Sciences +17
Recent Progress in Pyridazin-3(2H)-Ones Chemistry
Sang‐Gyeong Lee, Jeum‐Jong Kim, Ho-Kyun Kim et al. · Current Organic Chemistry · 2004 · 59 citations